Literature DB >> 17652899

Prevalence and impact of renal insufficiency on clinical outcomes of patients undergoing coronary revascularization.

Qiang Zhang1, Chang-Sheng Ma, Shao-Ping Nie, Xin Du, Qiang Lv, Jun-Ping Kang, Yin Zhang, Rong Hu, Chang-Qi Jia, Xin-Min Liu, Xiao-Hui Liu, Jian-Zeng Dong, Fang Chen, Yu-Jie Zhou, Shu-Zheng Lv, Fang-Jiong Huang, Cheng-Xiong Gu, Xue-Si Wu.   

Abstract

BACKGROUND: Patients with renal insufficiency are more likely to die after coronary revascularization, but mild renal insufficiency is neglected and little is known about its clinical effects. METHODS AND
RESULTS: In the present study 3,025 patients grouped by estimated creatinine clearance (CrCl) were analyzed to evaluate the association between CrCl and clinical outcome. The mean serum creatinine was 1.0+/-0.4 mg/dl, with 4.3% above normal; in 65.8% CrCl was <90 ml/min. During hospitalization, there were significant differences in mortality among the groups stratified by CrCl (p<0.0001). During follow-up after hospital discharge, there were significant differences in mortality (p<0.0001), new-onset myocardial infarction (p=0.007), and stroke (p=0.032). In patients with severe renal insufficiency, the in-hospital and follow-up mortality reached 15.4% and 31.3%, respectively. The independent risk factors for all-cause death after revascularization were the mode of revascularization, age and the CrCl level. In patients with mild renal insufficiency or normal renal function, the all-cause mortality after percutaneous coronary intervention was significantly lower than that after CABG.
CONCLUSIONS: Renal insufficiency is not rare in patients undergoing coronary revascularization and in the present study even mild renal insufficiency correlated with adverse clinical outcomes after revascularization. In patients with normal renal function or mild renal insufficiency, the mode of revascularization might lead to a prognostic difference.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17652899     DOI: 10.1253/circj.71.1299

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


  6 in total

1.  Renal function predicts survival in patients with acute ischemic stroke.

Authors:  Elizabeth Mostofsky; Gregory A Wellenius; Amit Noheria; Emily B Levitan; Mary R Burger; Gottfried Schlaug; Murray A Mittleman
Journal:  Cerebrovasc Dis       Date:  2009-05-20       Impact factor: 2.762

2.  Mode of Coronary Revascularization and Short term Clinical Outcomes in Patients with Chronic Kidney Disease.

Authors:  Ashique Ali Khoso; Khawar Abbas Kazmi; Saqiba Tahir; Hasanat Sharif; Safia Awan
Journal:  Pak J Med Sci       Date:  2014 Nov-Dec       Impact factor: 1.088

3.  Impact of mild preoperative renal insufficiency on in-hospital and long-term outcomes after off-pump coronary artery bypass grafting: a retrospective propensity score matching analysis.

Authors:  Qiang Ji; LiMin Xia; YunQing Shi; RunHua Ma; ChunSheng Wang; YunQing Mei; WenJun Ding
Journal:  J Cardiothorac Surg       Date:  2016-02-18       Impact factor: 1.637

4.  Comparison between three different equations for the estimation of glomerular filtration rate in predicting mortality after coronary artery bypass.

Authors:  Sandro Gelsomino; Massimo Bonacchi; Fabiana Lucà; Fabio Barili; Stefano Del Pace; Orlando Parise; Daniel M Johnson; Michele Massimo Gulizia
Journal:  BMC Nephrol       Date:  2019-10-16       Impact factor: 2.388

5.  Preoperative estimated glomerular filtration rate as a significant predictor of long-term outcomes after coronary artery bypass grafting in Japanese patients.

Authors:  Satoru Domoto; Osamu Tagusari; Yoshitsugu Nakamura; Hideaki Takai; Yoshimasa Seike; Yujiro Ito; Yuko Shibuya; Fumiaki Shikata
Journal:  Gen Thorac Cardiovasc Surg       Date:  2013-08-15

6.  Outcomes Following Coronary Artery Bypass Graft Surgery in Patients with Mild Preoperative Renal Insufficiency.

Authors:  Weitie Wang; Yuefeng Wang; Rihao Xu; Junwu Chai; Wei Zhou; Honglei Chen; Kai Wang; Xiangrong Kong
Journal:  Braz J Cardiovasc Surg       Date:  2018 Mar-Apr
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.